DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock
$6,78
السعر · أغسطس 18, 2026
البيانات الأساسية اعتبارًا من أغسطس 6, 2026
نطاق 52 أسبوعًا
$5–$18
12% of range
تقييم المحللين
SELL
10 analysts
السعر المستهدف
$7
+3% upside
P/E (TTM)
-1.3
ROE
-55.8%
هامش صافي الربح
-183.8%
حول Ginkgo Bioworks Holdings, Inc. Class A Common Stock نظرة عامة على الشركة من ويكيبيديا
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.
اقرأ المزيد
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.
History
In 2014, Ginkgo was the first biotechnology company to join the Y Combinator start-up accelerator program.
On 16 December 2020, it was reported that Ginkgo Bioworks would acquire the primary assets of Novogy's Microbial Engineering Platform. 2020 also saw the company acquire property worth $25 million from Marcus Partners for the construction of a new 219,000 square foot laboratory building, after razing existing structures, located in the Raymond L Flynn Marine Park. As of 2021, the company also occupied 200,000 square feet of the Innovation and Design Building (aka IDB) in the Park. Ginkgo also occupied facilities in Cambridge, where most MIT-spin outs resided at the time.
Growth of Ginkgo up to 2021 had been driven by "robust venture capital funding" and entry into the COVID-19 testing market. This included $45 million from Viking Global in 2015.
On 11 May 2021, Ginkgo Bioworks announced plans of going public through a merger with SPAC Soaring Eagle at a $17.5 billion valuation.
On 14 May 2021, Ginkgo announced its new ticker for the NYSE will be "DNA". The ticker was previously used by Genentech, who stopped using the ticker after they were acquired by Roche. Trading began on September 17, 2021. The investment management firm Baillie Gifford became the largest shareholder (15%) with the purchase of 167.75 million shares on 31 March 2022.
On 14 March 2022, it was reported that Ginkgo Bioworks signed a Definitive Agreement to Acquire FGen AG, a leading bioengineering company and its proprietary ultra-high-throughput screening platform.
On 6 June 2022, it was reported that Ginkgo Bioworks has acquired assets from real-time metabolite monitoring company, Bitome.
On 25 July 2022, Ginkgo Bioworks agreed to acquire Zymergen for $300 million in an all-stock deal.
On 27 July 2022, it was reported that Ginkgo Bioworks would acquire Bayer's Biologics Research & Development site, located in West Sacramento. Ginkgo will enter into a new multi-year platform collaboration with Bayer. The deal includes the integration of the R&D platform assets from Joyn Bio, a joint-venture between Leaps by Bayer investments and Ginkgo Bioworks.
On 4 October 2022, it was reported that Ginkgo Bioworks would acquire France-based adaptive laboratory evolution instruments developer Altar and California-based Circularis to strengthen capabilities in cell and gene therapy.
In October 2022, Bloomberg News reported that Ginkgo Bioworks partnered with Intelligence Advanced Research Projects Activity to create a software tool to help detect when biological organisms have been genetically engineered. The tool known as ENDAR (short for Engineered Nucleotide Detection and Ranking) could be used to provide an early warning of bioweapons and other man-made biological threats.
Fraud allegations
On 6 October 2021, a market research firm published a report accusing Ginkgo of embellishing its revenue in a complex scheme highly dependent on related-party transactions. The report prompted an inquiry into Ginkgo by the United States Department of Justice. In November 2021, Ginkgo was sued in a shareholder lawsuit alleging it misrepresented its revenue sources in statements regarding its merger with a special-purpose acquisition company. As of 2021, the company could not name a single significant product that is manufactured and sold using its organisms.
In March 2023, the former Attorney General of Louisiana launched an investigation into the officers and directors of Ginkgo.
المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗
DNA لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
السعر
$6.78
القيمة السوقية
$418M
P/E (TTM)
-1.3
ربح السهم (آخر 12 شهرًا)
$-5.64
الإيرادات (آخر 12 شهرًا)
$170M
عائد التوزيعات
—
ROE
-55.8%
D/E الدين/حقوق الملكية
—
نطاق 52 أسبوعًا
$5 – $18
DNA مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
Configure
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
الإيرادات وصافي الدخل
$170M
2019-12-31
→
2025-12-31
ربح السهم
$-5.64
2019-12-31
→
2025-12-31
التدفق النقدي الحر
$-179M
2022-12-31
→
2025-12-31
الهوامش
-183.8%
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
المقياس
اتجاه 5 سنوات
DNA
متوسط الأقران
P/E (TTM)
-1.3
17.5
P/S (TTM) (السعر / المبيعات (آخر 12 شهرًا))
2.5
3.3
P/B (السعر / القيمة الدفترية)
0.8
2.1
Price / FCF (السعر / التدفق النقدي الحر)
-2.3
—
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
المقياس
اتجاه 5 سنوات
DNA
متوسط الأقران
Operating Margin (هامش التشغيل)
-185.3%
—
Net Profit Margin (هامش صافي الربح)
-183.8%
-56.5%
ROA (العائد على الأصول)
-25.1%
-17.2%
ROE
-55.8%
-41.3%
ROIC
-61.8%
—
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
المقياس
اتجاه 5 سنوات
DNA
متوسط الأقران
Current Ratio (النسبة الحالية)
4.9
4.9
Quick Ratio (النسبة السريعة)
4.7
—
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
المقياس
اتجاه 5 سنوات
DNA
متوسط الأقران
Revenue YoY (الإيرادات مقارنة بالعام السابق)
-25.1%
—
Revenue CAGR 3Y (معدل نمو الإيرادات السنوي المركب لـ 3 سنوات)
-29.1%
—
Revenue CAGR 5Y (معدل نمو الإيرادات السنوي المركب لـ 5 سنوات)
17.3%
—
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
المقياس
اتجاه 5 سنوات
DNA
متوسط الأقران
DNA توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
بيع
10 محللين
- شراء قوي 0 0,0%
- شراء 1 10,0%
- احتفاظ 2 20,0%
- بيع 5 50,0%
- بيع قوي 2 20,0%
السعر المستهدف لمدة 12 شهرًا
2 محللين · 2026-08-15
الوسيط
$7.00
الآن
$6.78
منخفض
$5.00
مرتفع
$9.00
السعر المستهدف الوسيط
$7.00
+3,3%
السعر المستهدف المتوسط
$7.00
+3,3%
سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
متوسط المفاجأة
0.05%
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 30 يونيو، 2026 | $-0.75 | $-0.92 | 0.17% |
| 31 مارس، 2026 | $-1.39 | $-1.09 | -0.30% |
| 31 ديسمبر، 2025 | $-1.41 | $-1.47 | 0.06% |
| 30 سبتمبر، 2025 | $-1.45 | $-1.25 | -0.20% |
| 30 يونيو، 2025 | $-1.10 | $-1.58 | 0.48% |
| 31 مارس، 2025 | $-1.68 | $-1.79 | 0.11% |
مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| DNA | $484M | -1.5 | -25.1% | -183.8% | -55.8% | — |
| AZTA | $1.32B | -23.5 | 3.5% | -9.4% | -3.3% | 45.5% |
| CYRX | $479M | 6.9 | 12.4% | 44.4% | 15.3% | 47.1% |
| CTKB | $649M | 505.0 | 0.52% | -33.0% | -18.5% | 51.8% |
| MLAB | $489M | 73.1 | 3.4% | 2.7% | 3.7% | 63.5% |
| OABI | — | — | — | — | — | — |
| TKNO | $204M | -11.9 | 7.3% | -42.6% | -23.8% | 33.2% |
| PACB | $565M | -1.0 | 3.9% | -341.5% | -1634.9% | 28.6% |
| LAB | $495M | -6.4 | -6.2% | -87.8% | -17.6% | 49.9% |
| LFCR | $249M | -5.3 | 0.47% | -30.0% | -461.3% | 31.3% |
| CDXS | $147M | -3.3 | 18.6% | -62.5% | -82.8% | — |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 15
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $170M | $227M | $251M | $478M | $314M | $77M | $54M | |
| R&D Expense | $244M | $424M | $581M | $1.05B | $1.15B | $160M | $96M | |
| SG&A Expense | $183M | $246M | $385M | $1.43B | $863M | $38M | $29M | |
| Operating Expenses | $485M | $787M | $1.12B | $2.69B | $2.14B | $214M | $126M | |
| Operating Income | $-315M | $-560M | $-864M | $-2.21B | $-1.83B | $-137M | $-72M | |
| Interest Expense | · | · | $93.0K | $106.0K | $2M | $2M | $2M | |
| Other Non-op | $2M | $12M | $-29M | $88M | $-10M | $12M | · | |
| Pretax Income | $-314M | $-548M | $-893M | $-2.12B | $-1.84B | $-125M | $-120M | |
| Income Tax | $-837.0K | $-479.0K | $-71.0K | $-15M | $-1M | $2M | $22.0K | |
| Net Income | $-313M | $-547M | $-893M | $-2.10B | $-1.83B | $-127M | $-119M | |
| EPS (Basic) | $-5.64 | $-10.54 | $-18.37 | $-50.15 | $-1.35 | $-0.10 | $-0.10 | |
| EPS (Diluted) | $-5.64 | $-10.54 | $-18.37 | $-50.20 | $-1.39 | $-0.10 | $-0.10 | |
| Shares (Basic) | 55,457,676 | 51,894,639 | 48,610,507 | 41,976,537 | 1,359,849,000 | 1,274,766,915 | 1,149,000,417 | |
| Shares (Diluted) | 55,457,676 | 51,894,639 | 48,610,507 | 41,995,972 | 1,360,373,000 | 1,274,766,915 | 1,149,000,417 | |
| EBITDA | $-315M | $-560M | $-864M | $-2.21B | · | · | · |
الميزانية العمومية 28
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $167M | $562M | $944M | $1.32B | $1.55B | $381M | $495M | |
| Short-term Investments | $255M | $0 | · | · | · | · | · | |
| Receivables | $24M | $22M | $17M | $81M | $132M | $17M | · | |
| Inventory | · | · | $46.0K | $4M | $3M | $3M | · | |
| Prepaid Expense | $25M | $19M | $40M | $52M | $34M | $21M | · | |
| Other Current Assets | · | · | $362.0K | $487.0K | $698.0K | $680.0K | · | |
| Current Assets | $472M | $603M | $1.00B | $1.45B | $1.72B | $427M | · | |
| PP&E (Net) | $167M | $204M | $188M | $315M | $146M | $121M | · | |
| PP&E (Gross) | $355M | $365M | $309M | $408M | $207M | $155M | · | |
| Accum. Depreciation | $188M | $161M | $121M | $93M | $61M | $34M | · | |
| Goodwill | · | $0 | $49M | $60M | $21M | $2M | $2M | |
| Intangibles | $53M | $73M | $83M | $111M | $22M | $3M | · | |
| Other Non-current Assets | $9M | $55M | $58M | $89M | $44M | $6M | · | |
| Total Assets | $1.12B | $1.38B | $1.67B | $2.54B | $2.07B | $675M | · | |
| Accounts Payable | $11M | $14M | $9M | $10M | $8M | $14M | · | |
| Accrued Liabilities | · | · | · | $115M | $93M | $31M | · | |
| Short-term Debt | · | · | · | · | · | $300.0K | · | |
| Current Liabilities | $96M | $107M | $164M | $173M | $135M | $73M | · | |
| Capital Leases | $417M | $439M | $222M | $413M | $0 | · | · | |
| Other Non-current Liabilities | $23M | $17M | $24M | $31M | $36M | $3M | · | |
| Total Liabilities | $611M | $661M | $568M | $803M | $504M | $205M | · | |
| Common Stock | $6.0K | $5.0K | $5.0K | $190.0K | $161.0K | $129.0K | · | |
| Paid-in Capital | $6.66B | $6.56B | $6.39B | $6.14B | $3.80B | $929M | · | |
| Retained Earnings | $-6.15B | $-5.84B | $-5.29B | $-4.40B | $-2.30B | $-468M | · | |
| AOCI | $2M | $-2M | $1M | $-3M | $-2M | $0 | · | |
| Stockholders' Equity | $509M | $716M | $1.10B | $1.74B | $1.57B | $470M | · | |
| Liabilities + Equity | $1.12B | $1.38B | $1.67B | $2.54B | $2.07B | $675M | · | |
| Shares Outstanding | 58,207,298 | 54,365,785,000 | 50,032,873 | 47,299,399 | 40,284,804 | 1,288,596,000 | · |
التدفق النقدي 16
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $59M | $63M | $71M | $43M | $29M | $14M | $11M | |
| Stock-based Comp | $82M | $112M | $230M | $1.93B | $1.61B | $476.0K | $771.0K | |
| Deferred Tax | $-1M | $-936.0K | $-801.0K | $-15M | $0 | $0 | · | |
| Amort. of Intangibles | $19M | $18M | $16M | $6M | $1M | $500.0K | $500.0K | |
| Restructuring | $11M | $19M | · | · | · | · | · | |
| Operating Cash Flow | $-171M | $-320M | $-296M | $-252M | $-254M | $-136M | $-45M | |
| CapEx | $8M | $63M | $41M | $52M | $57M | $58M | $22M | |
| Investing Cash Flow | $-240M | $-62M | $-81M | $-67M | $-73M | $-67M | $-75M | |
| Stock Issued | $19M | $0 | $0 | · | · | · | · | |
| Stock Repurchased | · | · | · | · | · | · | $408.0K | |
| Net Stock Activity | $19M | · | · | · | · | · | · | |
| Financing Cash Flow | $18M | $-2M | $-3M | $95M | $1.53B | $90M | $410M | |
| Net Change in Cash | $-393M | $-384M | $-380M | $-223M | $1.21B | $-113M | $291M | |
| Taxes Paid | $192.0K | $0 | $23.0K | $981.0K | $9M | $0 | · | |
| Free Cash Flow | $-179M | $-382M | $-336M | $-304M | · | · | · | |
| Levered FCF | · | · | $-336M | $-305M | · | · | · |
الربحية 7
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -185.3% | -246.5% | -343.8% | -462.4% | · | · | · | |
| Net Margin | -183.8% | -240.9% | -355.1% | -440.6% | · | · | · | |
| Pretax Margin | -184.3% | -241.2% | -355.1% | -444.1% | · | · | · | |
| EBITDA Margin | -185.3% | -246.5% | -343.8% | -462.4% | · | · | · | |
| ROA | -25.1% | -36.0% | -42.5% | -91.3% | · | · | · | |
| ROE | -55.8% | -72.3% | -76.0% | -132.4% | · | · | · | |
| ROIC | -61.8% | -78.1% | -78.8% | -126.3% | · | · | · |
السيولة والملاءة 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | 5.6 | 6.1 | 8.4 | · | · | · | |
| Quick Ratio | 4.7 | 5.4 | 5.9 | 8.1 | · | · | · | |
| Interest Coverage | · | · | -9294.7 | -20839.2 | · | · | · |
الكفاءة 2
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.1 | 0.2 | · | · | · | |
| Receivables Turnover | 7.4 | 11.6 | 5.1 | 4.5 | · | · | · |
معدلات النمو 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -25.1% | -9.7% | -47.4% | 52.2% | 309.4% | · | · | |
| Revenue CAGR 3Y | -29.1% | -10.2% | 48.6% | · | · | · | · | |
| Revenue CAGR 5Y | 17.3% | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 10
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $170M | $227M | $251M | $478M | $314M | · | · | |
| Net Income TTM | $-313M | $-547M | $-893M | $-2.10B | $-1.83B | · | · | |
| Market Cap | $484M | $534M | $135.29B | $127.90B | · | · | · | |
| P/E | -1.5 | -0.9 | -3.7 | -1.3 | -239.1 | · | · | |
| P/S | 2.8 | 2.4 | 538.0 | 267.7 | · | · | · | |
| P/B | 1.0 | 0.7 | 123.3 | 73.7 | · | · | · | |
| P / Tangible Book | 1.1 | 0.8 | 140.2 | 81.7 | 351.4 | · | · | |
| P / Cash Flow | -2.8 | -1.7 | -457.8 | -507.1 | · | · | · | |
| P / FCF | -2.7 | -1.4 | -402.3 | -420.1 | · | · | · | |
| Earnings Yield | -67.9% | -107.3% | -27.2% | -74.3% | -0.42% | · | · |
قائمة الدخل 15
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20M | $19M | $33M | $39M | $39M | $38M | $44M | $89M | $56M | $38M | $35M | $55M | $81M | $81M | $98M | $66M | |
| Cost of Revenue | $2M | $3M | · | · | $5M | $4M | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $46M | $50M | $50M | $69M | $53M | $71M | $76M | $77M | $134M | $136M | $117M | $157M | $144M | $163M | $178M | $261M | |
| SG&A Expense | $31M | $38M | $46M | $45M | $35M | $40M | $57M | $52M | $66M | $70M | $89M | $82M | $102M | $111M | $121M | $435M | |
| Operating Expenses | $79M | $91M | $104M | $129M | $97M | $119M | $147M | $144M | $279M | $216M | $213M | $342M | $265M | $296M | $329M | $721M | |
| Operating Income | $-59M | $-71M | $-71M | $-90M | $-58M | $-81M | $-104M | $-55M | $-223M | $-178M | $-178M | $-286M | $-184M | $-216M | $-231M | $-655M | |
| Other Non-op | $1M | $-5M | $-11M | $9M | $5M | $-2M | $-4M | $-2M | $6M | $12M | $-34M | $-17M | $11M | $11M | $43M | $-15M | |
| Pretax Income | $-57M | $-76M | $-81M | $-81M | $-53M | $-83M | $-108M | $-57M | $-217M | $-166M | $-212M | $-303M | $-173M | $-205M | $-188M | $-670M | |
| Income Tax | $128.0K | $-80.0K | $-643.0K | $1.0K | $-283.0K | $88.0K | $-325.0K | $-375.0K | $190.0K | $31.0K | $-198.0K | $-22.0K | $67.0K | $82.0K | $-15M | $-28.0K | |
| Net Income | $-47M | $-83M | $-81M | $-81M | $-60M | $-91M | $-108M | $-56M | $-217M | $-166M | $-212M | $-303M | $-173M | $-205M | $-175M | $-670M | |
| EPS (Basic) | $-0.75 | $-1.39 | $-1.41 | $-1.45 | $-1.10 | $-1.68 | $-1.92 | $-1.08 | $-4.23 | $-3.31 | $-11.96 | $-6.21 | $-0.09 | $-0.11 | $-48.96 | $-0.41 | |
| EPS (Diluted) | · | · | $-1.41 | $-1.45 | $-1.10 | $-1.68 | $-1.91 | $-1.08 | $-4.23 | $-3.32 | $-11.96 | $-6.21 | $-0.09 | $-0.11 | $-49.01 | $-0.41 | |
| Shares (Basic) | 62,094,356 | 59,563,454 | -109,276,643 | 55,633,718 | 54,858,982 | 54,241,619 | -101,827,409 | 52,240,559 | 51,370,029 | 50,111,460 | -3,848,559,493 | 48,770,000 | 1,933,437,000 | 1,914,963,000 | -3,211,245,963 | 1,630,911,000 | |
| Shares (Diluted) | · | · | -109,276,643 | 55,633,718 | 54,858,982 | 54,241,619 | -101,860,455 | 52,246,129 | 51,375,599 | 50,133,366 | -3,850,233,493 | 48,770,000 | 1,933,437,000 | 1,916,637,000 | -3,211,226,528 | 1,630,911,000 | |
| EBITDA | $-59M | $-71M | · | $-90M | $-66M | $-89M | · | $-55M | $-223M | $-178M | · | $-286M | $-184M | $-216M | · | $-653M |
الميزانية العمومية 25
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85M | $144M | $167M | $111M | $204M | $312M | $562M | $616M | $730M | $840M | $944M | $1.05B | $1.11B | $1.21B | $1.32B | $1.30B | |
| Short-term Investments | · | · | $255M | $384M | $356M | $13M | $0 | · | · | · | · | · | · | · | · | · | |
| Receivables | $13M | $20M | $24M | $21M | $22M | $26M | $22M | $23M | $19M | $24M | · | $62M | $68M | $83M | · | $114M | |
| Inventory | · | · | · | · | · | · | · | · | · | · | · | $70.0K | $391.0K | $3M | · | $6M | |
| Prepaid Expense | $17M | $16M | $25M | $22M | $26M | $20M | $19M | $22M | $34M | $38M | · | $29M | $48M | $34M | · | $38M | |
| Current Assets | $333M | $410M | $472M | $506M | $523M | $565M | $603M | $662M | $783M | $903M | · | $1.14B | $1.22B | $1.33B | · | $1.46B | |
| PP&E (Net) | $157M | $163M | $168M | $177M | $186M | $198M | $204M | $211M | $211M | $196M | · | $202M | $294M | $314M | · | $188M | |
| PP&E (Gross) | $355M | $352M | $358M | $359M | $360M | $361M | $365M | $362M | $347M | $326M | · | $322M | $413M | $421M | · | $271M | |
| Accum. Depreciation | $198M | $189M | $191M | $182M | $173M | $163M | $161M | $151M | $136M | $130M | · | $121M | $118M | $107M | · | $83M | |
| Goodwill | · | · | · | · | · | · | $0 | $0 | $0 | $48M | $49M | $58M | $59M | $59M | $60M | $29M | |
| Intangibles | $44M | $49M | $57M | $62M | $66M | $69M | $73M | $80M | $91M | $77M | · | $100M | $105M | $109M | · | $48M | |
| Other Non-current Assets | $1M | $40M | $47M | $47M | $47M | $47M | $55M | $60M | $60M | $61M | · | $97M | $98M | $97M | · | $44M | |
| Total Assets | $990M | $1.03B | $1.12B | $1.19B | $1.23B | $1.29B | $1.38B | $1.48B | $1.63B | $1.58B | · | $2.03B | $2.29B | $2.42B | · | $1.87B | |
| Accounts Payable | $10M | $16M | $11M | $11M | $11M | $11M | $14M | $16M | $23M | $27M | · | $11M | $14M | $22M | · | $11M | |
| Current Liabilities | $73M | $80M | $96M | $115M | $97M | $116M | $107M | $114M | $166M | $169M | · | $168M | $163M | $192M | · | $125M | |
| Capital Leases | $404M | $411M | $417M | $423M | $429M | $435M | $439M | $446M | $452M | $234M | · | $404M | $411M | $404M | · | · | |
| Other Non-current Liabilities | $16M | $22M | $23M | $17M | $18M | $15M | $17M | $18M | $21M | $25M | · | $19M | $20M | $29M | · | $35M | |
| Total Liabilities | $570M | $590M | $611M | $629M | $618M | $646M | $661M | $683M | $792M | $594M | · | $774M | $788M | $810M | · | $431M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $206.0K | $202.0K | · | $198.0K | $196.0K | $194.0K | · | $165.0K | |
| Paid-in Capital | $6.70B | $6.67B | $6.66B | $6.63B | $6.60B | $6.58B | $6.56B | $6.53B | $6.51B | $6.45B | · | $6.33B | $6.28B | $6.21B | · | $5.67B | |
| Retained Earnings | $-6.28B | $-6.23B | $-6.15B | $-6.07B | $-5.99B | $-5.93B | $-5.84B | $-5.73B | $-5.67B | $-5.46B | · | $-5.08B | $-4.78B | $-4.60B | · | $-4.23B | |
| AOCI | $950.0K | $1M | $2M | $2M | $2M | $-850.0K | $-2M | $263.0K | $-2M | $-2M | · | $-3M | $-1M | $-2M | · | $-8M | |
| Stockholders' Equity | $420M | $443M | $509M | $560M | $613M | $647M | $716M | $798M | $833M | $987M | $1.10B | $1.25B | $1.50B | $1.61B | $1.74B | $1.43B | |
| Liabilities + Equity | $990M | $1.03B | $1.12B | $1.19B | $1.23B | $1.29B | $1.38B | $1.48B | $1.63B | $1.58B | · | $2.03B | $2.29B | $2.42B | · | $1.87B | |
| Shares Outstanding | 63,711,102 | 61,660,788 | 58,207,298 | 56,836,246 | 55,425,334 | 54,698,246 | 54,365,785 | 53,082,000 | 2,078,737,000 | 2,033,624,000 | 50,032,873 | 1,972,725,000 | 1,954,704,000 | 1,933,880,000 | 47,299,399 | 1,648,263,224 |
التدفق النقدي 12
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $13M | $14M | $14M | $16M | $15M | $16M | $17M | $17M | $13M | $13M | $21M | $18M | $19M | $16M | $8M | |
| Stock-based Comp | $8M | $16M | $21M | $18M | $22M | $17M | $21M | $14M | $37M | $41M | $43M | $53M | $61M | $73M | $108M | $563M | |
| Amort. of Intangibles | $4M | $4M | $5M | $5M | $4M | $4M | $5M | $5M | $5M | $3M | $3M | $4M | $4M | $4M | $3M | $1M | |
| Restructuring | · | · | $706.0K | $2M | $4M | · | $-666.0K | $3M | $12M | · | · | $0 | $0 | · | · | · | |
| Operating Cash Flow | $-44M | $-47M | $-48M | $-32M | $-40M | $-52M | $-42M | $-104M | $-84M | $-89M | $-58M | $-74M | $-74M | $-91M | $-105M | $-28M | |
| CapEx | $3M | $2M | $5.0K | $0 | $38.0K | $8M | $14M | $15M | $27M | $7M | $3M | $4M | $14M | $19M | $26M | $13M | |
| Investing Cash Flow | $11M | $23M | $95M | $-73M | $-64M | $-199M | $-13M | $-10M | $-27M | $-12M | $-47M | $-3M | $-11M | $-19M | $30M | $-46M | |
| Stock Issued | · | · | $9M | $10M | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $16M | $-19.0K | $8M | $10M | $-98.0K | $-207.0K | $-203.0K | $-465.0K | $-226.0K | $-845.0K | $-632.0K | $-315.0K | $-1M | $-888.0K | $98M | $-280.0K | |
| Net Change in Cash | $-17M | $-24M | $55M | $-94M | $-104M | $-250M | $-56M | $-114M | $-111M | $-102M | $-105M | $-77M | $-87M | $-111M | $24M | $-75M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Free Cash Flow | · | $-49M | · | · | · | $-59M | · | · | · | $-96M | · | · | · | $-110M | · | · |
الربحية 7
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -290.5% | -366.5% | · | -231.8% | -132.1% | -184.1% | · | -62.0% | -396.7% | -469.1% | · | -516.7% | -228.6% | -267.3% | · | -983.5% | |
| Net Margin | -231.7% | -424.1% | · | -207.9% | -121.6% | -188.2% | · | -63.3% | -386.4% | -437.2% | · | -546.4% | -215.1% | -254.0% | · | -1007.6% | |
| Pretax Margin | -283.8% | -391.0% | · | -207.9% | -122.1% | -188.1% | · | -63.8% | -386.1% | -437.2% | · | -546.5% | -215.0% | -253.9% | · | -1007.7% | |
| EBITDA Margin | -290.5% | -366.5% | · | -231.8% | -132.1% | -184.1% | · | -62.0% | -396.7% | -469.1% | · | -516.7% | -228.6% | -267.3% | · | -983.5% | |
| ROA | -4.2% | -7.1% | · | -6.0% | -4.2% | -6.3% | · | -3.2% | -11.1% | -8.3% | · | -15.5% | -8.1% | -9.2% | · | -33.3% | |
| ROE | -9.0% | -15.2% | · | -11.9% | -8.3% | -11.1% | · | -5.5% | -18.6% | -12.8% | · | -22.5% | -11.4% | -12.9% | · | -44.8% | |
| ROIC | -14.0% | -16.1% | · | -16.1% | -10.6% | -13.8% | · | -6.9% | -26.8% | -18.0% | · | -22.9% | -12.2% | -13.4% | · | -45.5% |
السيولة والملاءة 2
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 5.2 | · | 4.4 | 5.4 | 4.9 | · | 5.8 | 4.7 | 5.3 | · | 6.8 | 7.5 | 6.9 | · | 11.7 | |
| Quick Ratio | 1.3 | 2.1 | · | 4.5 | 6.0 | 3.0 | · | 5.6 | 4.5 | 5.1 | · | 6.6 | 7.2 | 6.7 | · | 11.3 |
الكفاءة 2
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 1.1 | 0.8 | · | 1.7 | 2.4 | 1.9 | · | 2.1 | 1.3 | 0.7 | · | 0.6 | 0.7 | 0.6 | · | 0.8 |
التقييم (آخر 12 شهرًا) 10
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $118M | $146M | · | $226M | $243M | $232M | · | $239M | $230M | $255M | · | $283M | $372M | $460M | · | $457M | |
| Net Income TTM | $-270M | $-315M | · | $-288M | $-425M | $-530M | · | $-742M | $-859M | $-847M | · | $-1.35B | $-1.72B | $-2.13B | · | $-2.03B | |
| Market Cap | $631M | $378M | · | $829M | $624M | $312M | · | $433M | $27.77B | $94.36B | · | $142.83B | $145.43B | $102.88B | · | $205.70B | |
| P/E | -1.9 | -1.2 | · | -2.7 | -1.4 | -0.6 | · | -0.5 | -1.0 | -4.8 | · | -10.6 | -72.9 | -40.9 | · | -98.3 | |
| P/S | 5.4 | 2.6 | · | 3.7 | 2.6 | 1.3 | · | 1.8 | 120.7 | 370.6 | · | 504.5 | 390.6 | 223.6 | · | 450.1 | |
| P/B | 1.5 | 0.9 | · | 1.5 | 1.0 | 0.5 | · | 0.5 | 33.3 | 95.6 | · | 114.0 | 96.7 | 64.0 | · | 143.4 | |
| P / Tangible Book | 1.7 | 1.0 | · | 1.7 | 1.1 | 0.5 | · | 0.6 | 37.4 | 109.5 | · | 130.5 | 108.6 | 71.4 | · | 151.5 | |
| P / Cash Flow | · | -8.1 | · | · | · | -6.1 | · | · | · | -1057.2 | · | · | · | -1135.8 | · | · | |
| P / FCF | · | -7.8 | · | · | · | -5.3 | · | · | · | -983.2 | · | · | · | -935.1 | · | · | |
| Earnings Yield | -53.6% | -86.6% | · | -36.4% | -71.9% | -180.9% | · | -182.1% | -103.7% | -21.0% | · | -9.4% | -1.4% | -2.4% | · | -1.0% |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الإيرادات | $170M | $227M | $251M | $478M | $314M |
| هامش الربح التشغيلي % | -185.3% | -246.5% | -343.8% | -462.4% | — |
| صافي الدخل | $-313M | $-547M | $-893M | $-2.10B | $-1.83B |
| EPS المخفف | $-5.64 | $-10.54 | $-18.37 | $-50.20 | $-1.39 |
الميزانية العمومية
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| النسبة الحالية | 4.9 | 5.6 | 6.1 | 8.4 | — |
| النسبة السريعة | 4.7 | 5.4 | 5.9 | 8.1 | — |
التدفق النقدي
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $-179M | $-382M | $-336M | $-304M | — |
آخر الأخبار أحدث العناوين التي تذكر هذه الشركة
- أسهم "السبعة الرائعة" التي تراهن عليها كاثي وود الآن
- Yahoo announces AI-powered experiences for Yahoo Finance and Yahoo Sports
- This Warren Buffett Stock Is Beating the S&P 500 in 2026
- قاضٍ عام كاليفورنيا يتهم شركة 23andMesuccessor بخصوص اختراق بيانات 2023
- حظر إعلانات مجموعات مسحات الحمض النووي الذاتية باعتبارها مضللة
- جيم كرامر عن BillionToOne: "أقول اشتروها"
- كيف ألهمت حروق الشمس طريقة جديدة لتخزين الطاقة
- دعوى قضائية ضد بائعي الماريجوانا لعدم التحذير من المخاطر المزعومة
- صعود Zcash بنسبة 30% في شهر واحد، هل هو استثمار أفضل من البيتكوين؟
- SCHQ ضد TLT: نفس حمض نووي للخزانة، ولكن بتكلفة ومدّة مختلفة تمامًا
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
📊
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.
الملاك المؤسسيون (13F) 204 مقدمي إقرار · $269.0M إجمالي · حتى تاريخ 30 يونيو، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
النشاط المؤسسي — Q2 2026 مقابل الربع السابق
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 39 (+13 مقابل الربع السابق) | 17 (-11 مقابل الربع السابق) | 65 (+23 مقابل الربع السابق) | 35 (-12 مقابل الربع السابق) | +6.2M |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | $35449338 | 3577128 | 13,18% | الأسهم |
| Erste Asset Management GmbH | $25902147 | 2536939 | 9,63% | الأسهم |
| BAILLIE GIFFORD & CO | $23701242 | 2391649 | 8,81% | الأسهم |
| VANGUARD CAPITAL MANAGEMENT LLC | $20685074 | 2087293 | 7,69% | الأسهم |
| Anchorage Capital Group, L.L.C. | $17306457 | 1746363 | 6,43% | الأسهم |
| STATE STREET CORP | $14591187 | 1472370 | 5,43% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $10292812 | 1038369 | 3,83% | الأسهم |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $9293628 | 937803 | 3,46% | الأسهم |
| Allianz Asset Management GmbH | $7787258 | 785798 | 2,90% | الأسهم |
| MILLENNIUM MANAGEMENT LLC | $6329279 | 638676 | 2,35% | الأسهم |
| SB INVESTMENT ADVISERS (UK) LTD | $6052324 | 610729 | 2,25% | الأسهم |
| Prescott Group Capital Management, L.L.C. | $5369684 | 541845 | 2,00% | الأسهم |
| GOLDMAN SACHS GROUP INC | $5364154 | 541287 | 1,99% | الأسهم |
| RENAISSANCE TECHNOLOGIES LLC | $5349973 | 539856 | 1,99% | الأسهم |
| BANK OF AMERICA CORP /DE/ | $4760754 | 480399 | 1,77% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4109677 | 414700 | 1,53% | عقد خيار الشراء |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3910555 | 394607 | 1,45% | الأسهم |
| EXCHANGE TRADED CONCEPTS, LLC | $3555540 | 358783 | 1,32% | الأسهم |
| DIMENSIONAL FUND ADVISORS LP | $3480392 | 351200 | 1,29% | الأسهم |
| TUDOR INVESTMENT CORP ET AL | $3326886 | 335710 | 1,24% | الأسهم |
| VANGUARD FIDUCIARY TRUST CO | $3097598 | 312573 | 1,15% | الأسهم |
| Coastal Bridge Advisors, LLC | $2743256 | 276817 | 1,02% | الأسهم |
| BALANCE CAPITAL PARTNERS L.P. | $1972179 | 199009 | 0,73% | الأسهم |
| ALGERT GLOBAL LLC | $1784395 | 180060 | 0,66% | الأسهم |
| Susquehanna Portfolio Strategies, LLC | $1746449 | 176231 | 0,65% | الأسهم |
| BNP PARIBAS FINANCIAL MARKETS | $1637935 | 165281 | 0,61% | الأسهم |
| PEAK6 LLC | $1619294 | 163400 | 0,60% | عقد خيار الشراء |
| CAXTON ASSOCIATES LLP | $1532552 | 154647 | 0,57% | الأسهم |
| D. E. Shaw & Co., Inc. | $1499938 | 151356 | 0,56% | الأسهم |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $1387400 | 140000 | 0,52% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1297219 | 130900 | 0,48% | عقد خيار البيع |
| CITADEL ADVISORS LLC | $1233973 | 124518 | 0,46% | الأسهم |
| JPMORGAN CHASE & CO | $1154383 | 113064 | 0,43% | الأسهم |
| a16z Capital Management, L.L.C. | $1075909 | 108568 | 0,40% | الأسهم |
| CITADEL ADVISORS LLC | $1073253 | 108300 | 0,40% | عقد خيار الشراء |
| Numerai GP LLC | $1036606 | 104602 | 0,39% | الأسهم |
| AMERICAN CENTURY COMPANIES INC | $974718 | 98357 | 0,36% | الأسهم |
| WOLVERINE TRADING, LLC | $964467 | 72900 | 0,36% | عقد خيار الشراء |
| Ensign Peak Advisors, Inc | $931332 | 93979 | 0,35% | الأسهم |
| Bank of New York Mellon Corp | $818843 | 82628 | 0,30% | الأسهم |
| PANAGORA ASSET MANAGEMENT INC | $803592 | 81089 | 0,30% | الأسهم |
| MARSHALL WACE, LLP | $772356 | 77937 | 0,29% | الأسهم |
| Swiss National Bank | $744865 | 75163 | 0,28% | الأسهم |
| ALLSTATE CORP | $698209 | 70455 | 0,26% | الأسهم |
| Mariner, LLC | $667488 | 67359 | 0,25% | الأسهم |
| IEQ CAPITAL, LLC | $624766 | 63044 | 0,23% | الأسهم |
| ALLEN OPERATIONS LLC | $613935 | 61951 | 0,23% | الأسهم |
| RHUMBLINE ADVISERS | $610615 | 61617 | 0,23% | الأسهم |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $609079 | 61461 | 0,23% | الأسهم |
| TWO SIGMA INVESTMENTS, LP | $599099 | 60454 | 0,22% | الأسهم |
| BROWN ADVISORY INC | $586731 | 59206 | 0,22% | الأسهم |
| BlackRock, Inc. | $526895 | 53168 | 0,20% | الأسهم |
| EDGEWOOD MANAGEMENT LLC | $495500 | 50000 | 0,18% | الأسهم |
| WOLVERINE TRADING, LLC | $492156 | 37200 | 0,18% | عقد خيار البيع |
| Quadrature Capital Ltd | $456732 | 46088 | 0,17% | الأسهم |
| MORGAN STANLEY | $447427 | 45149 | 0,17% | الأسهم |
| Shay Capital LLC | $444384 | 44842 | 0,17% | الأسهم |
| LPL Financial LLC | $427257 | 43114 | 0,16% | الأسهم |
| CITIGROUP INC | $426893 | 43077 | 0,16% | الأسهم |
| JANE STREET GROUP, LLC | $414238 | 41800 | 0,15% | عقد خيار الشراء |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $387709 | 39123 | 0,14% | الأسهم |
| Casdin Capital, LLC | $361646 | 36493 | 0,13% | الأسهم |
| CITADEL ADVISORS LLC | $347841 | 35100 | 0,13% | عقد خيار البيع |
| Dynamic Technology Lab Private Ltd | $347000 | 34996 | 0,13% | الأسهم |
| ALLIANCEBERNSTEIN L.P. | $342005 | 55792 | 0,13% | الأسهم |
| GROUP ONE TRADING LLC | $326138 | 32910 | 0,12% | الأسهم |
| AlphaQuest LLC | $309788 | 37279 | 0,12% | الأسهم |
| Mitsubishi UFJ Asset Management Co., Ltd. | $301532 | 30427 | 0,11% | الأسهم |
| Welch & Forbes LLC | $297300 | 30000 | 0,11% | الأسهم |
| MetLife Investment Management, LLC | $285111 | 28770 | 0,11% | الأسهم |
| AXQ CAPITAL, LP | $262387 | 26477 | 0,10% | الأسهم |
| BARCLAYS PLC | $258919 | 26127 | 0,10% | الأسهم |
| IMC-Chicago, LLC | $240922 | 24311 | 0,09% | الأسهم |
| Man Group plc | $239901 | 24208 | 0,09% | الأسهم |
| VANGUARD ASSET MANAGEMENT, Ltd | $238425 | 24059 | 0,09% | الأسهم |
| CANADA PENSION PLAN INVESTMENT BOARD | $222975 | 22500 | 0,08% | الأسهم |
| Russell Investments Group, Ltd. | $222885 | 22491 | 0,08% | الأسهم |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $217356 | 21933 | 0,08% | الأسهم |
| Modera Wealth Management, LLC | $216316 | 21828 | 0,08% | الأسهم |
| MARTINGALE ASSET MANAGEMENT L P | $209062 | 21096 | 0,08% | الأسهم |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $203116 | 22345 | 0,08% | الأسهم |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $189123 | 30852 | 0,07% | الأسهم |
| Walleye Capital LLC | $188944 | 19066 | 0,07% | الأسهم |
| Invesco Ltd. | $186209 | 18790 | 0,07% | الأسهم |
| Trexquant Investment LP | $178420 | 18004 | 0,07% | الأسهم |
| SIMPLEX TRADING, LLC | $178330 | 17995 | 0,07% | الأسهم |
| Comprehensive Financial Management LLC | $174971 | 17656 | 0,07% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $172474 | 17404 | 0,06% | الأسهم |
| Boston Standard Wealth Management, LLC | $164995 | 15165 | 0,06% | الأسهم |
| DEUTSCHE BANK AG\ | $163763 | 16525 | 0,06% | الأسهم |
| Creative Planning | $156974 | 15840 | 0,06% | الأسهم |
| Vanguard Global Advisers, LLC | $155904 | 15732 | 0,06% | الأسهم |
| Squarepoint Ops LLC | $155478 | 15689 | 0,06% | الأسهم |
| MERCER GLOBAL ADVISORS INC /ADV | $153664 | 15506 | 0,06% | الأسهم |
| ExodusPoint Capital Management, LP | $148343 | 14969 | 0,06% | الأسهم |
| Police & Firemen's Retirement System of New Jersey | $146420 | 14775 | 0,05% | الأسهم |
| Entropy Technologies, LP | $138423 | 13968 | 0,05% | الأسهم |
| Green Alpha Advisors, LLC | $134241 | 13546 | 0,05% | الأسهم |
| VANGUARD GROUP INC | $130733 | 15732 | 0,05% | الأسهم |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $127690 | 12885 | 0,05% | الأسهم |
المطلعون على الشركة 17 من المطلعين · مسؤولون 5 · مديرون 13
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| Jason R Kelly | Chief Executive Officer & Founder | 28 يوليو، 2026 A | 3894680 | 0 | 0 | $0 |
| Steven P. Coen | Chief Financial Officer | 16 يوليو، 2026 M | 51438 | 0 | 1 | $-5941 |
| Mark E. Dmytruk | Chief Financial Officer | 20 مايو، 2025 M | 46226 | 0 | 0 | $0 |
| Reshma P. Shetty | President & Founder | 28 يوليو، 2026 A | 12374544 | 0 | 0 | $0 |
| Marie E. Fallon | Chief Accounting Officer | 1 مايو، 2023 M | 183010 | 0 | 0 | $0 |
| Sri Kosuri | مدير | 11 يونيو، 2026 A | 24067 | 0 | 0 | $0 |
| Ross Fubini | مدير | 11 يونيو، 2026 A | 10822 | 0 | 0 | $0 |
| Christian O Henry | مدير | 11 يونيو، 2026 A | 24310 | 0 | 2 | $-219800 |
| Harry Sloan | مدير | 11 يونيو، 2026 A | 271418 | 0 | 0 | $0 |
| Shyam Sankar | مدير | 12 يونيو، 2025 A | 72372 | 0 | 0 | $0 |
| Kathy Hopinkah Hannan | مدير | 11 يونيو، 2025 M | 15003 | 0 | 0 | $0 |
| Myrtle S Potter | مدير | 11 يونيو، 2025 M | 10822 | 0 | 0 | $0 |
| Arie Belldegrun | مدير | 13 يونيو، 2024 A | 194925 | 0 | 0 | $0 |
| Reshma Kewalramani | مدير | 12 يونيو، 2024 M | 186002 | 0 | 0 | $0 |
| Marijn E Dekkers | مدير | 12 يونيو، 2024 M | 386480 | 0 | 0 | $0 |
| Eagle Equity Partners III, LLC | مدير | 16 سبتمبر، 2021 D | 31590948 | 0 | 0 | $0 |
| Barry Canton | مالك 10% | 28 يوليو، 2026 A | 12374544 | 0 | 0 | $0 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
الناشطون والمالكون بنسبة 5%+ 4 حيازات
المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.
| مقدم | مقدم | حصة | الحالة | الغرض | إيداع |
|---|---|---|---|---|---|
| Reshma P. Shetty, Barry Canton | 14 فبراير، 2025 | 9,50% | تعديل | — | SEC |
| Jason Kelly ×4 إيداعات | 14 فبراير، 2024 | — | إيداع أولي | — | SEC |
| Reshma Shetty, Bartholomew Canton ×4 إيداعات | 14 فبراير، 2024 | — | إيداع أولي | — | SEC |
| VIKING GLOBAL INVESTORS LP, VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, O. ANDREAS HALVORSEN, DAVID C. OTT, ROSE S. SHABET ×3 إيداعات | 4 مارس، 2022 | — | إيداع أولي | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 33 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| THNQ · EXCHANGE TRADED CONCEPTS TRUST | 0,84% | 321721 NS | 30 إبريل، 2026 | N-PORT |
| IDNA · iShares Trust | 0,44% | 101324 SH | 8 أغسطس، 2026 | يومي |
| IWC · iShares Trust | 0,09% | 161981 SH | 8 أغسطس، 2026 | يومي |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 187206 SH | 8 أغسطس، 2026 | يومي |
| IBB · iShares Trust | 0,03% | 368167 SH | 8 أغسطس، 2026 | يومي |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,03% | 91425 NS | 31 مايو، 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 41498 SH | 8 أغسطس، 2026 | يومي |
| IWN · iShares Trust | 0,03% | 442118 SH | 8 أغسطس، 2026 | يومي |
| IWM · iShares Trust | 0,01% | 1226249 SH | 8 أغسطس، 2026 | يومي |
| RSSL · Global X Funds | 0,01% | 18139 NS | 30 إبريل، 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 549889 SH | 8 أغسطس، 2026 | يومي |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 274008 SH | 8 أغسطس، 2026 | يومي |
| ITWO · ProShares Trust | 0,01% | 2005 NS | 31 مايو، 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,01% | 112735 SH | 8 أغسطس، 2026 | يومي |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 210534 NS | 31 مايو، 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 1567 NS | 31 مايو، 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 16982 NS | 30 إبريل، 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 1584 NS | 31 مايو، 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 2081 NS | 31 مايو، 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 4528 NS | 30 إبريل، 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 40 NS | 31 مايو، 2026 | N-PORT |
| VEGN · ETF Series Solutions | 0,00% | 252 NS | 30 إبريل، 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 19123 NS | 30 إبريل، 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 22130 SH | 8 أغسطس، 2026 | يومي |
| ITOT · iShares Trust | 0,00% | 66432 SH | 8 أغسطس، 2026 | يومي |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 26477 NS | 31 مايو، 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 3795 NS | 30 إبريل، 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 584 NS | 30 إبريل، 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 1182 NS | 30 إبريل، 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1489851 SH | 8 أغسطس، 2026 | يومي |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3264 SH | 8 أغسطس، 2026 | يومي |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 504 NS | 31 مايو، 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 1232 NS | 30 إبريل، 2026 | N-PORT |